Where Psychedelic Treatments Fit in Modern Clinical Care

Where Psychedelic Treatments Fit in Modern Clinical Care

How psychedelic-assisted therapy may complement ongoing mental health care through collaborative treatment models, continuity, and patient-centered support.

Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized ...

Updated TGA recommendations broaden therapist eligibility, accept a wider range of treatment settings, and reinforce Australia's position as the world's leading commercial market for prescribed psilocybin and MDMA

Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber F

Updated TGA recommendations broaden therapist eligibility, accept a wider range of treatment settings, and reinforce Australia's position as the world's leading commercial market for prescribed psilocybin and MDMA VANCOUVER, British Columbia, May 29, 2026 (GLOBE NEWSWIRE) -- via IBN – Optimi Health Corp. (NASDAQ:OPTH) (CSE:OPTI) (FSE: 8BN0) (the "Company" or "Optimi"), a commercial-stage psychedelic pharmaceutical manufacturer, today acknowledge…

Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia

Updated TGA recommendations broaden therapist eligibility, accept a wider range of treatment settings, and reinforce Australia's position as the world's leading commercial market for prescribed psilocybin and MDMA

Psychedelic-assisted therapies get a boost, but systems struggle to play catch-up - Pharmaceutical Technology

As the first psychedelics near approval, several other factors warrant attention to ensure effective and safe implementation.